Pharma-biotech cluster Current Affairs
Telangana Government has signed Memorandum of Understanding (MoU) with Singapore-based engineering & consulting firm Surbana Jurong for preparing roadmap for Genome Valley 2.0. It will be an upgraded version of life sciences and biotechnology industrial cluster state’s capital city Hyderabad.
Genome Valley is India’s first organized pharma-biotech cluster for life sciences R&D activities and largest life sciences destination in Asia, being home to over 200 companies employing 10,000 people. It is already home to multinationals such as Novartis, GlaxoSmithKline, DuPont, Mylan, US Pharmacopeia among others. It includes 6 of world’s top 10 R&D companies and three of India’s largest vaccine manufacturers.
The cluster was conceptualized in 1999 in Shamirpet, Hyderabad, India. It is spread over 600 sq kms in vicinity of Hyderabad. It is India’s first systematically developed R&D cluster, boasting world-class infrastructure facilities in form of Industrial/Knowledge Parks, Special Economic Zones (SEZs), Multi-tenanted wet laboratories and Incubation facilities. It synergizes a healthy mix of companies in realm of biopharma, vaccine manufacturing, agri-biotech, Clinical Research Management (CRM), regulatory and testing, and other related areas.
Genome Valley 2.0
Genome Valley 2.0 is vision to upgrade cluster into world-class knowledge led integrated corridor in self-sufficient life sciences ecosystem. It is being envisioned to transform into industry led knowledge based ecosystem to become a driver for local economic development. It will introduce world class knowledge cluster and lay master plan to transform the ecosystem into a smart satellite town of Hyderabad. Its expansion will enable more global companies to establish and expand their operations.